Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
IMMUNO-CELL INTERNATIONAL from Mechelen, company number BE0453361865, closed financial year 2025 with a result of € 478,283 after tax. For that financial year IMMUNO-CELL INTERNATIONAL recorded a gross margin of € 975,426 and equity of € 955,309. Compared with financial year 2024, the result moved from € 521,820 to € 478,283. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
€ 955,309
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 478,283
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 191,362
▲ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 180,000 paid out
38 % of the profit went to the shareholders, mostly to Orexys (85 % of the shares). That is where the money ends up.
People and assets in 2025
6.5
▼ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 242,988
▼ 27% vs 2024
€ 37,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 77,435
▲ 117% vs 2024
Of which on lease € 77,435.
Debts at end 2025
€ 211,142
▲ 93% vs 2024
€ 107,798 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 138,394
▲ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 21,690
▼ 26% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,099,145 | € 1,045,894 | € 1,106,170 | € 975,426 | ▼ 12% |
| Profit after taxes | € 563,640 | € 510,617 | € 521,820 | € 478,283 | ▼ 8% |
| Equity | € 474,589 | € 485,206 | € 657,026 | € 955,309 | ▲ 45% |
| Total debts | € 1,745,939 | € 1,189,580 | € 567,909 | € 604,085 | ▲ 6% |
| Cash | € 649,283 | € 639,270 | € 185,247 | € 191,362 | ▲ 3% |
| Retained profit | € 424,589 | € 435,206 | € 607,026 | € 905,309 | ▲ 49% |
| Dividend | € 950,000 | € 500,000 | € 350,000 | € 180,000 | ▼ 49% |
| Bank debt | € 180,771 | € 185,742 | € 109,238 | € 211,142 | ▲ 93% |
| Balance sheet total | € 2,220,528 | € 1,674,785 | € 1,224,934 | € 1,559,394 | ▲ 27% |
| Employees (FTE) | 5.5 | 7.1 | 7.3 | 6.5 | ▼ 0.8 |
Key figures of IMMUNO-CELL INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMUNO-CELL INTERNATIONAL?
What happened at IMMUNO-CELL INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 478,283 (▼ 8% vs 2024). Source: NBB ↗
- New establishment in Mechelen. KBO
- New establishment in Mechelen. KBO
- Start of the company according to the CBE. KBO
In short
From € 563,640 profit in 2022 to € 478,283 profit in 2025.
Paid € 694,401 in corporate taxes since 2022.
Best year ever: 2022, with € 563,640 profit.
On average € 150,100 of value added per employee in 2025.
Management
The stake of Orexys, HANOLA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
IMMUNO-CELL INTERNATIONALBehind IMMUNO-CELL INTERNATIONAL are Quentin Speeckaert and James Dehé. The shares are held by Orexys (85%) and HANOLA (15%).
Establishments
Establishment units
Physical locations of this company
Motstraat 72 box 8
2800 Mechelen
Motstraat 72 box 9
2800 Mechelen
Active since 1 February 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →EK REAL INVEST
€ 36,698 gross margin · 2025
D.W. PRINT
€ 158,821 gross margin · 2025
COMMUNICATION AND MARKETING PRODUCTIONS
€ 106,115 gross margin · 2025
JACCO DESIGN
€ 36,054 gross margin · 2025
UBIVISION
€ -5,472 gross margin · 2025
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0453.361.865
- VAT number
- BE 0453.361.865
- Registered office
- Motstraat 72 bus 8, 2800 Mechelen
- Names & denominations
- IMMUNO-CELL INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 August 1994
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van holglas
Overige activiteiten op het gebied van drukwerk
Overige drukkerijen
Groothandel in farmaceutische en medische artikelen
Overige detailhandel in nieuwe artikelen neg
Overige gespecialiseerde detailhandel in artikelen, andere dan voedingsmiddelen, n.e.g.
Groothandel in farmaceutische producten